Buffalo BioSciences :: Accelerating the Commercialization of Life Science Technologies
  
About Us
Our Team
Capabilities
Client Profiles
News & Events
Portfolio Companies
Industry Resources
     Local History
    White Papers
    Video Archives
    Links
Contact Us
Life Science CompaniesResearchersTechnology Transfer OrganizationsInvestorsEconomic Development Agencies
 
Local History of Innovation and Discovery

There are over 650 life science companies and research institutions within 100-miles of Buffalo, including established firms such as AstraZeneca Canada, MDS Proteomics, Baxter Corporation, Amgen Canada, GlaxoSmithKline and Pfizer Global. There is also rich local history of innovation and discovery in health, medicine and natural sciences:

  • The Nation's first cancer research, treatment and education center was established in Buffalo in 1899. Known today as Roswell Park Cancer Institute, it is one of two New York State cancer centers to hold the National Cancer Institute designation of "comprehensive cancer center" and is one of only 41 such centers in the United States.
  • The internal cardiac pacemaker was invented by Wilson Greatbatch and others in Buffalo, and stimulated the creation of Wilson Greatbatch Technologies (GB), a $700 million local company, which is a leading manufacturer of pacemaker and cardiac defibrillator batteries and components.
  • Beta-interferon (Avonex) therapy for Multiple Sclerosis was pioneered by the late Dr. Larry Jacobs, and is now produced by Biogen which currently sponsors research and support for the Jacobs Neurological Institute in Buffalo.
  • Development of high-throughput methods for automated crystal screening for proteomics and structural genomics was founded by Buffalo's Nobel Laureate, Dr. Herbert Hauptman. This discovery allows thousands of crystallization experiments to be performed in a shorter period of time which increases possible output to over 15,360 experiments per day.
  • Sickle cell anemia screening test was developed in Buffalo and is now administered to more than 22,000 people each year in the U.S.
  • Prostate-Specific Antigen (PSA) Test was developed by Roswell Park Cancer Institute researchers 1986 and is now the standard diagnostic blood test to predict prostate cancer.
  • Photodynamic Therapy (PDT), a two-step cancer therapy uses a light-sensitive drug (photosensitizer) and visible light to destroy cancer cells in solid tumors. This treatment was pioneered at Roswell Park Cancer Institute by Dr. Thomas J. Dougherty and colleagues and is now used to treat many skin and esophageal cancers.

Source: Buffalo Niagara Enterprise & BuffLink

Over 650 life science companies and research institutions can be found within 100-miles of BuffaloOver 650 life science companies and research institutions can be found within 100-miles of Buffalo
Over 650 life science companies and research institutions can be found within 100-miles of BuffaloOver 650 life science companies and research institutions can be found within 100-miles of Buffalo

 

 

site map | contact us | home